IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
an ti his ta mines sys temic 8%
func tional gas tro-in tes ti nal dis or der drugs 4%
Lead ing Dose Forms:
tab lets 66%
liq uids 24%
am poules 5%
gels/sols 3%
coated tab lets 1%
PANAMA
NOVARTIS
Full Name: Novartis Pharma (Lo gis tics), Inc.
Postal Ad dress: Apartado 0830-00659, Pan ama
9
Street Ad dress: Busi ness park, Torre Oeste 1
Piso, Parque de Oficinas Costa del Este, Pan ama
Tel: +507 301-44-84
Fax: +507 300-23-85
De scrip tion: Im porter, ex porter, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion). Es tab lished 1995.
Con tacts (Pharm): Chair man: Diego Cuesta;
Com mer cial Op er a tions: Marco Tay lor
Sub sid iary of: Novartis, Swit zer land (100%)
PERU
CIFARMA
Full Name: Cifarma S.A.
Postal Ad dress: Apartado Postal 43-047, Lima
Street Ad dress: Km 3.0 Carretera Cen tral
No.1315, Santa Anita, Lima 43
Tel: +51 1 618 62 00
Fax: +51 1 628 62 01
Email: cifarma@quimicasuiza.com
Home Page: www.cifarma.com.pe
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, packager/as sem bler, im porter, ex porter. De -
vel ops, for mu lates, man u fac tures, im ports,
ex ports for other com pa nies. Prod uct ranges in -
clude: phar ma ceu ti cal prod ucts (branded,
unbranded, pre scrip tion, non-pre scrip tion), di -
etetic/nu tri tional prod ucts, raw ma te ri als, den tal
prod ucts, herbal prod ucts, vet er i nary
pharmaceuticals. Es tab lished 1992. 135
pharmaceutical employees in 2008.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 0 (2008)
Con tacts (Pharm): Chair man: Carlos
Willstatter; Gen eral Con tact: Carlos Willstatter
Sub sid iary of: Quimica Suiza, Peru (100%)
NOVARTIS
Full Name: Novartis Bio sci ences Peru SA
Street Ad dress: Carretera Cen tral No. 1315,
Km. 3.0, Santa Anita, Lima 43
Tel: +51 1 494 27 88
Fax: +51 1 494 26 73
De scrip tion: Re searcher, packager/as sem bler,
im porter, pro moter, sales/detailer. Pro motes,
sells/de tails for other com pa nies. Prod uct ranges
in clude: phar ma ceu ti cal prod ucts (branded, pre -
scrip tion, non-pre scrip tion), oph thal mic prod ucts.
Es tab lished 1997. 66 phar ma ceu ti cal em ploy ees
in 2007. Di vi sions in clude: Novartis Con sumer
Health. Pharmaceuticals; Consumer Health.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 43 (2007)
Con tacts (Pharm): Chair man: Jorge Contieras;
Com mer cial Op er a tions: Carolina Lopez; Mar ket
Re search: Fiorela Mansilla; Re search & De vel op -
ment: Ricardo Avila
Phar ma ceu ti cal Sales: US$ 8-9 mil lion
Prod ucts (% of Sales by Lead ing 5): 50-55%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
TONOPAN (antimigraine prep a ra tion)
VOLTAREN (antirheumatic non-steroidal)
DIOVAN HCT (an gio ten sin-II an tag o nist com bi na -
tion)
DIOVAN (an gio ten sin-II an tag o nist plain)
TEGRETOL (antiepileptic)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 25%
anti rheu ma tics sys temic 20%
an al ge sics 13%
ophthalmologicals 11%
antiepileptics 10%
Lead ing Dose Forms:
coated tab lets 43%
tab lets 28%
liq uids 10%
am poules 8%
cap sules 7%
© 2009 IMS Health In cor po rated or its af fil i ates Page 194